Generical S.A Pharmaceutical Import Profile — Dominican Republic (DGFT 2022–2026)

Name: Generical S.A Pharmaceutical Import Records from India — 2 Products, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Generical S.A — Pharmaceutical Importer Profile (2026) | 2 Products, $1.4M Trade | TransData Nexus

Generical S.A

Pharmaceutical Importer · Dominican Republic · Respiratory Focus · $1.4M Total Trade · DGFT Verified

Generical S.A is a pharmaceutical importer based in Dominican Republic with a total trade value of $1.4M across 2 products in 1 therapeutic categories. Based on 27 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Generical S.A sources from 2 verified Indian suppliers, with Medispray Laboratories Private Limited accounting for 94.2% of imports.

Generical S.A — Import Portfolio & Supplier Network

Generical S.A import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Generical S.A?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Medispray Laboratories Private Limited	$1.2M	43	94.2%
Cipla Limited	$73.3K	6	5.8%

Generical S.A sources from 2 verified Indian suppliers across .

What Formulations Does Generical S.A Import?

Formulation	Value	Ships
Airplus venticaps (twin Pack) with	$300.0K	6
Airplus venticaps (twin pck	$150.0K	3
Airplus venticaps(twin pck)formoterol fumarate 6mcg+budesonide 200mcg rotacaps)(19274packx1x60's=1156440 nos)(twin Pack)	$100.0K	2
Airplus venticaps(twin pck)formoterol fumarate 6mcg+budesonide 200mcg rotacaps)(19392packx1x60's=1163520 nos)(twin Pack)	$100.0K	2
Airplus venticaps(twin pck)formoterol fumarate 6mcg+budesonide 200mcg rotacaps)(19445packx1x60's=1166700 nos)(twin Pack)	$100.0K	2
Airplus venticaps(twin Pack)with	$50.0K	1
Nicardia - xl 30MG tablets (nifedipine	$50.0K	1
Airplus venticaps (twin pck)(formoterolfumarate 6mcg+ budesonide 200mcg rotacaps )(1x60's x19776packs=1186560 nos	$50.0K	1
Airplus venticaps (twin pck)(formoterolfumarate 6mcg+ budesonide 200mcg rotacaps )(1x60's x19727packs=1183620 nos	$50.0K	1
Airplus venticaps (twin pck)(formoterolfumarate 6mcg+ budesonide 200mcg rotacaps )(1x60's x19638packs=1178280 nos	$50.0K	1
Airplus venticaps (twin Pack)with revolizer(formoterol fumarate 6mcg+budesonide200mcg rotacaps)(1x60'sx19800	$50.0K	1
Airplus venticaps(twin pck)formoterol fumarate 6mcg+budesonide 200mcg rotacaps)(19514packx1x60's=1170840 nos)(twin Pack)	$50.0K	1
Airplus venticaps(twin pck)formoterol fumarate 6mcg+budesonide 200mcg rotacaps) (19514packx1x60's=1170840 nos)(twin	$50.0K	1
Nicardia - xl 30MG tablets (nifedipine tablets 30MG)(19800 packs x2x14s= 554400 nos)	$50.0K	1
Duovent 2.5 ML respules (ipratropium	$29.6K	1

Generical S.A imports 29 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Formoterol	Respiratory	$750.0K	15	1.3%	11
2	Budesonide	Respiratory	$600.0K	12	0.3%	15

Generical S.A imports 2 pharmaceutical products across 1 categories into Dominican Republic totaling $1.4M.

Generical S.A — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Generical S.A. is a pharmaceutical importer based in the Dominican Republic, specializing in the acquisition of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company plays a pivotal role in the Dominican Republic's pharmaceutical distribution network, ensuring the availability of essential medications to meet the healthcare needs of the population. While specific details about its parent company are not publicly disclosed, Generical S.A. operates independently, focusing on sourcing and importing pharmaceutical products from international suppliers.

2Distribution Network

Generical S.A. maintains a centralized distribution hub in Santo Domingo, the capital city of the Dominican Republic. This strategic location enables efficient logistics and timely delivery of pharmaceutical products across the nation. The company's distribution network is designed to ensure that imported medications reach various healthcare facilities, pharmacies, and hospitals throughout the country, thereby supporting the national healthcare infrastructure.

3Industry Role

In the Dominican Republic's pharmaceutical supply chain, Generical S.A. functions primarily as a wholesaler and distributor. By importing finished pharmaceutical formulations from international suppliers, the company bridges the gap between global manufacturers and local healthcare providers. This role is crucial in ensuring that a diverse range of medications is accessible to meet the therapeutic needs of the Dominican population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Generical S.A

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Generical S.A. exhibits a high degree of sourcing concentration, with a total import value of $1.4 million USD from India across 27 shipments. The company's portfolio is entirely focused on two products—Formoterol and Budesonide—imported from two suppliers: Medispray Laboratories Private Limited and Cipla Limited. This concentrated sourcing strategy may offer benefits such as streamlined logistics and potentially favorable pricing agreements. However, it also introduces risks related to supply chain disruptions, regulatory changes, or quality control issues with these suppliers. The absence of diversification in both product offerings and supplier base suggests a strategic choice to maintain simplicity and control over the supply chain, but it also highlights the need for contingency planning to mitigate potential risks.

2Supply Chain Resilience

The resilience of Generical S.A.'s supply chain is closely tied to its reliance on a limited number of suppliers and products. The company's focus on Formoterol and Budesonide, sourced exclusively from Medispray Laboratories Private Limited and Cipla Limited, respectively, means that any disruptions affecting these suppliers could significantly impact Generical S.A.'s ability to meet market demand. Additionally, the concentration of shipments from a single country—India—exposes the company to risks associated with geopolitical events, regulatory changes, or logistical challenges in that region. To enhance supply chain resilience, Generical S.A. might consider diversifying its supplier base and product portfolio, thereby reducing dependency on specific suppliers and regions.

Importing Pharmaceuticals into Dominican Republic — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Dominican Republic

1Regulatory Authority & Framework

The Dirección General de Medicamentos, Alimentos y Productos Sanitarios (DIGEMAPS) is the primary regulatory authority overseeing pharmaceutical imports in the Dominican Republic. Under Law No. 50-88 on Drugs and Controlled Substances, amended by Law 35-90, DIGEMAPS is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products entering the country. Pharmaceutical companies must obtain a Sanitary Register from DIGEMAPS for each product they intend to import. This registration process involves submitting comprehensive documentation, including product formulations, manufacturing processes, and clinical trial data, to demonstrate compliance with national health standards. The Sanitary Register is valid for five years and must be renewed upon expiration.

2Import Licensing & GMP

Import licensing is mandatory for pharmaceutical products entering the Dominican Republic. Companies must secure a Sanitary Register from DIGEMAPS for each product, as previously mentioned. Additionally, adherence to Good Manufacturing Practices (GMP) is a critical requirement. DIGEMAPS recognizes GMP certifications from reputable international bodies, including the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their suppliers hold valid GMP certifications from these recognized organizations to facilitate the importation process. Furthermore, wholesale distribution authorization is required to operate within the Dominican Republic, ensuring that companies comply with local regulations governing the storage, handling, and distribution of pharmaceutical products.

Generical S.A — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Generical S.A.'s focus on importing Formoterol and Budesonide, both respiratory medications, indicates a strategic alignment with the therapeutic needs of the Dominican Republic's population. Respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), are prevalent in the region, driving demand for effective treatments. By concentrating on these products, Generical S.A. aims to address a significant segment of the healthcare market, ensuring that patients have access to essential medications for managing respiratory conditions.

2Sourcing Profile

Generical S.A.'s sourcing strategy is centered on importing generic pharmaceutical formulations from India, a country known for its robust pharmaceutical manufacturing sector. The company's preference for finished formulations over raw active pharmaceutical ingredients (APIs) suggests a focus on ready-to-use products that can be directly distributed to healthcare providers. This approach allows Generical S.A. to offer a range of medications without the complexities associated with manufacturing processes. India's competitive pricing and established reputation for quality generics make it an attractive sourcing destination for Generical S.A.

3Market Positioning

Seller's Guide — How to Become a Supplier to Generical S.A

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Dominican Republic market by partnering with Generical S.A. The company's established distribution network and focus on respiratory medications create a conducive environment for introducing additional products within this therapeutic area. Potential gaps in Generical S.A.'s current sourcing include the need for alternative suppliers to mitigate risks associated with supplier concentration and the introduction of new formulations to meet evolving patient needs. Indian exporters can leverage these opportunities by ensuring compliance with Dominican regulatory standards and offering competitive pricing and reliable delivery schedules.

2Requirements & Qualifications

Indian exporters seeking to supply Generical S.A. and the broader Dominican Republic market must ensure that their products are registered with DIGEMAPS and comply with local GMP standards. Obtaining GMP certifications from recognized international bodies such as WHO and PIC/S is essential. Additionally, products must meet labeling requirements, including Spanish language labeling and adherence to serialization mandates. Exporters should also be prepared to provide comprehensive documentation, including product formulations, manufacturing processes, and clinical trial data, to facilitate the Sanitary Register application process.

Frequently Asked Questions — Generical S.A

What products does Generical S.A import from India?

Generical S.A imports 2 pharmaceutical products across 1 categories. Top imports: Formoterol ($750.0K), Budesonide ($600.0K).

Who supplies pharmaceuticals to Generical S.A from India?

Generical S.A sources from 2 verified Indian suppliers. The primary supplier is Medispray Laboratories Private Limited (94.2% of imports, $1.2M).

What is Generical S.A's total pharmaceutical import value?

Generical S.A's total pharmaceutical import value from India is $1.4M, based on 27 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Generical S.A focus on?

Generical S.A imports across 1 categories. The largest: Respiratory (100.0%).

Get Full Generical S.A Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.